Clinical trials in Africa are not always conducted according to leading ethical guidelines. This puts clinical trial participants at risk of being physically harmed or having their rights violated. This is the main message of this report from Wemos. Wemos therefore urges the European Medicines Agency (EMA) to be more stringent when evaluating unethical clinical trials and to be more transparent about how it aims to guarantee that trials are ethical.